Home » Stocks » TEAR

TearLab Corporation (TEAR)

Jul 9, 2020 - TEAR was delisted (reason: acquired)
Stock Price: $0.0579 USD -0.0011 (-1.86%)
Updated Jul 9, 2020 4:00 PM EDT
Market Cap 1.41M
Revenue (ttm) 22.06M
Net Income (ttm) -5.64M
Shares Out 24.41M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day Jul 9, 2020
Last Price $0.0579
Previous Close $0.0590
Change ($) -0.0011
Change (%) -1.86%
Day's Open -
Day's Range 0.0570 - 0.0579
Day's Volume 0
52-Week Range 0.0201 - 0.2150

News

There are no news available yet.

About TEAR

TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. The company offers TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab Pen, a hand-held device that i... [Read more...]

Industry
Diagnostics & Research
IPO Date
Dec 8, 2004
CEO
Joseph S. Jensen
Employees
39
Stock Exchange
OTCMKTS
Ticker Symbol
TEAR
Full Company Profile

Financial Performance

In 2019, TearLab's revenue was $22.66 million, a decrease of -9.38% compared to the previous year's $25.00 million. Losses were -$5.42 million, 140.6% more than in 2018.

Financial Statements